Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferation (Q35027305)

5 August 2017

Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferation (English)

1 reference

5 August 2017

1 reference

Gantner F

1

1 reference

5 August 2017

Götz C

2

1 reference

5 August 2017

Gekeler V

3

1 reference

5 August 2017

Schudt C

4

1 reference

5 August 2017

Wendel A

5

1 reference

5 August 2017

Hatzelmann A

6

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

British Journal of Pharmacology

5 August 2017

1 reference

5 August 2017

123

1 reference

5 August 2017

6

1 reference

5 August 2017

1031-1038

1 reference

Differential effect of phosphodiesterase 4 inhibitors on the proliferation of human peripheral blood mononuclear cells from normals and subjects with atopic dermatitis

5 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

Cyclic AMP-elevating agents prolong or inhibit eosinophil survival depending on prior exposure to GM-CSF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

Cholera toxin promotes the proliferation of anti-μ antibody-prestimulated human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

An improved assay of cyclic 3',5'-nucleotide phosphodiesterases with QAE-Sephadex columns

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Molecular biology of the cyclic AMP-specific cyclic nucleotide phosphodiesterases: a diverse family of regulatory enzymes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Role of cyclic AMP in the modulation of IgE production by the beta 2-adrenoceptor agonist, fenoterol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Phosphodiesterase inhibitors suppress proliferation of peripheral blood mononuclear cells and interleukin-4 and -5 secretion by human T-helper type 2 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Expression and regulation of human and rat phosphodiesterase type IV isogenes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

A molecular analysis of PGE receptor (EP) expression on normal and transformed B lymphocytes: coexpression of EP1, EP2, EP3beta and EP4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Protection by phosphodiesterase inhibitors against endotoxin-induced liver injury in galactosamine-sensitized mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: a comparative study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Agonistic and antagonistic effects of cholera toxin on human B lymphocyte proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Elevated leukocyte cyclic AMP—phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP—agonist hyporesponsiveness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Cyclic AMP has the ability to influence multiple events during B cell stimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

The cDNA of a human lymphocyte cyclic-AMP phosphodiesterase (PDE IV) reveals a multigene family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

The role of adrenoceptor-mediated signals in the modulation of lymphocyte function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

The specific type III and IV phosphodiesterase inhibitor zardaverine suppresses formation of tumor necrosis factor by macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Cyclic nucleotide phosphodiesterase isoenzyme activities in human alveolar macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Cyclic nucleotide phosphodiesterases from purified human CD4+ and CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Mdr1/P-glycoprotein expression in natural killer (NK) cells enriched from peripheral or umbilical cord blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701688

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0701688

1 reference

release_nqxvzijmhjfxxpkdk32vudk5t4

5 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nqxvzijmhjfxxpkdk32vudk5t4

24 November 2022

mapped directly with Wikidata item

PMCID

1565253

1 reference

5 August 2017

1 reference